medigraphic.com
ISSN 1561-3054 (Electronic)

2013, Number 1

<< Back Next >>

Rev Cubana Med Trop 2013; 65 (1)

Prevalence of infection caused by Entamoeba histolytica in public schools of Maceio city, Alagoas, Brazil

Cavalcanti DIA, Vital SR, Fontes G, Fonte GL, Arraes de Alencar XR, Vieira MMA, da Silva AI, Maurício DEM

Language: Spanish
References: 24
Page: 4-12
PDF size: 88.24 Kb.


ABSTRACT

Introduction: distribution of amebiasis has been reevaluated since it was demonstrated that two morphologically indistinguishable species of Entamoeba exist, but they differ in their capacity to cause disease: Entamoeba histolytica (pathogenic) and Entamoeba dispar (nonpathogenic). The use of techniques to identify specific antigenic characteristics makes it possible to establish differential diagnosis and to assess the actual prevalence of amebiasis cases (caused only by Entamoeba histolytica).
Objective: to determine the prevalence of infection by Entamoeba histolytica/Entamoeba dispar complex and, in a second phase, the prevalence of infection by Entamoeba histolytica in stool samples of students from public schools in Maceió, Alagoas, Brazil.
Methods: screening of Entamoeba histolytica/Entamoeba dispar complex infection cases was carried out by formol-ether concentration technique on stool samples of 1 798 students. The infection caused by this complex was confirmed with an enzyme linked immunosorbent assay (ENZYMEBA). Positive samples were then analyzed with a specific ELISA (Entamoeba histolytica II®) in order to detect an adesin only present in Entamoeba histolytica.
Results: the microscopic observation of feces and the Enzymeba test allowed demonstrating the prevalence of Entamoeba histolytica/Entamoeba dispar infection amounting to 3.8 %. The Entamoeba histolytica II procedure showed the prevalence of infection by Entamoeba histolytica of 1.0%. Therefore, the microscopy presented a low predictive positivity value (26.4%) for detection of Entamoeba histolytica compared to Entamoeba histolytica II® method.
Conclusions: although the prevalence figures are not high, the study shows for the first time the occurrence of Entamoeba histolytica in Maceió, Alagoas, Brazil. In spite of the fact that the optical microscopic test of feces is not the appropriate technique for amebiasis diagnosis, it can be used as a screening method in epidemiological studies. Cases of Entamoeba histolytica infection in positive samples by microscopy can be confirmed by using a specific test for detection of the parasite coproantigen like Entamoeba histolytica II®.


REFERENCES

  1. Diamond L, Clark CG. A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925. J Euk Microbiol. 1993;40:340-4.

  2. Delialioglu N, Aslan G, Sozen M, Babur C, Kanik A, Emekdos G. Detection of Entamoeba histolytica/Entamoeba dispar in stool specimens by using Enzyme-linked Immunosorbent Assay. Mem Inst Oswaldo Cruz. 2004;99:769-72.

  3. Nozaki T, Aca IS, Okuzawa E, Magalhães M, Tateno S, Takeuchi T. Zymodemes of Entamoeba histolytica isolated in the Amazon and the Northeast of Brazil. Trans R Soc Trop Med Hyg. 1990;84:387-8.

  4. Tanyuksel M, Yilmaz H, Ulukanligil M, Araz E, Cicek M, Koru O, et al. Comparison of two methods (microscopy and enzyme-linked immunorbent assay) for the diagnosis of amebiasis. Exp Parasitol. 2005;110:322-6.

  5. World Health Organization - WHO News and activities. Entamoeba taxonomy. Bull World Health Org. 1997;75:291-2.

  6. Haque R, Neville IM, Hahn P, Petri JrWA. Rapid diagnosis of Entamoeba infection by using Entamoeba and Entamoeba histolytica stool antigen detection kits. J Clin Microbiol. 1995;33:2558-61.

  7. Haque R, Ali IKM, Akter S, Petri JrWA. Comparison of PCR, isoenzyme analysis, and antigen detection for diagnosis of Entamoeba histolytica infeccion. J Clin Microbiol. 1998;36:449-52.

  8. Haque R, Ali IKM, Petri JrWA. Prevalence and imune response to Entamoeba histolytica in preschool children in Bangladesh. Am J Trop Med Hyg. 1999;60:1031-4.

  9. Póvoa MM, Arruda JEG, Silva MCMS, Bichara CN, Esteves P, Gabbay YB, et al. Diagnóstico de amebíase intestinal utilizando métodos coproscópicos e imunológicos em amostra da população da área metropolitana de Belém, Pará, Brasil. Cad Saude Publica. 2000;16:843-6.

  10. Braga LLC, Gomes ML, Silva MW, Paiva C, Sales A, Mann BJ. Entamoeba histolytica and Entamoeba dispar infections as detected by monoclonal antibody in an urban slum in Fortaleza, Northeastern Brazil. Rev Soc Bras Med Trop. 2001;84:467-71.

  11. Tachibana H, Kobayashi S, Paz KC, Aca IS, Tateno S, Ihara S. Analysis of pathogenicity by restriction-endonuclease digestion of amplified genomic DNA of Entamoeba histolytica isolated in Pernambuco, Brazil. Parasitol Res. 1992;78:433-6.

  12. Pinheiro SMB, Carneiro RM, Aca IS, Irmão JI, Morais JrMA, Coimbra MRM, et al. Determination of the prevalence of Entamoeba histolytica and E. dispar in the Pernambuco state of Northeastern Brazil by a Polymerase Chain Reaction. Am J Trop Med Hyg. 2004;70:221-4.

  13. Aca IS, Kobayashi S, Carvalho JrLB, Tateno S, Takeuchi T. Prevalence and pathogenicity of Entamoeba histolytica in three different regions of Pernambuco, Northeast Brazil. Rev Inst Med Trop Sao Paulo. 1994;36:519-24.

  14. Luaces AL, Picó T, Barret AJ. The Enzymeba test: detection of intestinal Entamoeba histolytica infection by immunoenzimatic detection of histolysain. Parasitology. 1992;105:203-5.

  15. Nesbitt RA, Mosha FW, Katki HA, Ashraf M, Assenga C, Lee CM. Amebiasis and comparison of microscopy to Elisa technique in detection of Entamoeba histolytica and Entamoeba dispar. J Natl Med Assoc. 2004;96:671-7.

  16. Hudson CD, Petri WA. Amebiasis: Clinical implications of the recognition of Entamoeba dispar. Curr Infect Dis Rep. 1999;1:441-7.

  17. Fonte, L, Fernández FN, Montalvo AM, Rivero LR, Amador, EA. Enzymeba, procedimiento eficaz para estudiar la prevalencia de infección intestinal por Entamoeba histolytica. Rev Cubana Hig Epidemiol. 1998;36:131-6.

  18. Núñez YO, Fernández FN, Torres-Núñez D, Silva JA, Montano I, Maestre JL, et al. Multiplex polymerase chain reaction amplification and differentiation of Entamoeba histolytica and Entamoeba dispar DNA from stool samples. Am J Trop Med Hyg. 2001;64:293-7.

  19. Stark D, Van Hal S, Fotedar A, Marriott D, Ellis J, Harkness J. Comparison of stool antigen detection kits to PCR for diagnosis of amebiasis. J Clin Microbiol. 2008:46:1678-81.

  20. Pillai DR, Keystone JS, Sheppard DC, MacLean JD, MacPherson DW, Kain, KC. Entamoeba histolytica and Entamoeba dispar: Epidemiology and comparison of diagnostic methods in a setting of nonendemicity. Clin Infect Dis. 1999;29:1315-8.

  21. Kebede A, Verweij JJ, Petros B, Polderman AM. Misleading microscopy in amoebiasis. Trop Med Int Health. 2004;9:651-2.

  22. Haque R, Faruque ASG, Hahn P, Lyerly DM, Petri JrWA. Entamoeba histolytica and Entamoeba dispar infection in children in Bangladesh. J Infect Dis. 1997;175:734-6.

  23. Braga LLBC, Gomes ML, Silva MW, Façanha JrFE, Fiuza L, Mann BJ. Household epidemiology of Entamoeba histolytica infection in an urban community in Northeastern Brazil. Am J Trop Med Hyg. 2001;65:268-71.

  24. Santos F, Goncalves M, Soares N. Validation and utilization of PCR for differential diagnosis and prevalence determination of Entamoeba histolytica/Entamoeba dispar in Salvador City, Brazil. Braz J Infect Dis. 2011:15:119-25.




2020     |     www.medigraphic.com